Group B streptococci carriers in pregnant women;Portación de estreptococo grupo B en mujeres embarazadas

Revista Argentina de Microbiologia

Volumn 35, Issue 4, 2003, Pages 183-187

  Garcia S D ^a   Eliseth, M Cora ^a   Lazzo, M J ^b   Copolillo, E ^a   Barata, A D ^a   De Torres, R ^b   Vay, C A ^a   Famiglietti, A M R ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Group B streptococci; Pregnant carriers

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN INFECTION; NEWBORN MORTALITY; PERINATAL INFECTION; PREGNANCY; STREPTOCOCCUS AGALACTIAE; THIRD TRIMESTER PREGNANCY; VAGINA;

ADOLESCENT; ADULT; ANAL CANAL; ARGENTINA; CARRIER STATE; CULTURE MEDIA; DRUG RESISTANCE; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PREVALENCE; RECTUM; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINOSIS, BACTERIAL;

EID: 0345827770     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th ed, WB Saunders. Co, Philadelphia, p. 980-1054.
2. Baker CJ (1997) Group B streptococcal infections. Clin. Perinatol. 24: 59-70.
3. Benitz WE, Gould JB, Druzzin ML (1999) Risk factors for early onset group B Streptococcal Sepsis. Pediatrics.103(6).URL: http://www.pediatrics.org/cgi/Content/full/103/6/e77.
4. Boyer KM, Gadzala Cal, Kelly PD, Burd L (1983) Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-inset disease II. Predictive value if prenatal cultures. J. Infect. Dis. 148: 802-809.
5. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease (1996) A public health perspective. MMWR 45: 1-24.
6. Committe on Infectious Disease and Committee on Fetus and Newborn, American Academy of Pediatrics (1997) Revised guidelines for prevention of early onset group B streptococcal (GBS) infection. Pediatrics 35: 267-280.
7. Committee on Obstetric Practice, American College of Obstetricians and Gynecologist (1996) Prevention of early onset group Streptococcal disease in newborns. American College of Obstetricians and Ginecologist, Washington, DC; ACOG No 173.
8. Copolillo E, Perazzi B, Vay C, Cora Eliseth M, Tauscher P, Barata A, Famiglietti A (2000) Metodología diagnóstica para las infecciones del tracto genital inferior durante el embarazo. Ginecol. Reprod. 7: 76.
9. Cueto M, Sánchez MJ, Miranda J.A, Rosa-Fraile M (1998) Timing of intrapartum ampicillin and prevention if vertical transmission of group B Streptoccocus Obstet. Gynecol. 91: 112-114.
10. Famiglietti A, De Mier C, Rodríguez H, Almuzara M, Barberis C, Vay C (1999) Epidemiology and susceptibility of group B Streptococcus in an Argentina University Hospital. En: Voto LS, Margulies M, Cosmi EV (Ed), 4° World Congress of Perinatal Medicine, Monduzzi, Bologna, Italy, p. 631-634.
11. Juncosa T, Bosch J, Dopico E, Guardia C, Lite J, Sierra M et al (1998) Infección neonatal por Streptococcus agalactiae. Estudio multicéntrico en el área de Barcelona. Enf. Inf. Microbio. Clin. 16: 312-315.
12. Juncosa T, Muñoz C, Gené A, Fortea J, Latorre C (1996) Infecciones neonatales por Streptococcus agalactiae. An Esp. Pediatr. 45: 153-156.
13. López Sastre J, Coto Cotallo (1997) Sepsis de transmisión vertical. XXVII Congreso de la Asociación Española de Pediatría, Resumen 1: 63-66, Barcelona, España.
14. Murdach DR, Reller B (2001) Antimicrobial susceptibilities of Group B streptococci isolated from patients with invasive disease: 10 years perspective. Antimicrob. Agents Chemother. 45: 3623-3624.
15. National Committee for Clinical Laboratory Standards (2001) Performance standard for antimicrobial suceptibility testing, eighth informational supplement M 100 S 8.18 (1). Villanova, USA.
16. Ocampo-Torres M, Sánchez-Pérez H, Nazar-Beutelspacher A, Castro-Ramírez A, Cordero-Ocampo B (2000) Factores asociados a la colonización por Streptococcus del grupo B en mujeres embarazadas de Los Altos, Chiapas. Salud Pu̇blica de México 42: 413-421.
17. Schuchat A (1998) Epidemiology of group B streptococcal disease in the United States: Shifting Paradigms Clin. Microbiol. Rev. 11: 497-513.
18. Sharon L, Hillier PD (1997) Preventing neonatal Group B streptococcal disease: the role of the clinical microbiology laboratory. Clin. Microbiol. News 19: 113-117.
19. Zangwill KM, Schuchat A, Wenger JD (1992) Report from a multiestate active surveillance system. MMWR CDC Surveill Simn. 41: 25-32.